Literature DB >> 33107315

Management of Patients with Liver Transplant and Chronic Liver Diseases During COVID-19 Pandemic: A Brief Review.

Mohammad Taher1,2, Arash Miroliaee2, Nasser Ebrahimi Daryani2, Foroogh Alborzi Avanaki2, Najmeh Aletaha2, Mohsen Nasiri-Toosi1,2, Habibollah Dashti1,3, Vahid Basirat2, Ali Jafarian1,3.   

Abstract

The coronavirus associated disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has rapidly spread all around the world and became pandemic in March 2020. Data on liver transplantation and chronic liver disease during the pandemic has remained scarce, and there is little information on whether immunosuppressed patients are at higher risk of developing severe COVID-19 infection. This review provides information for health care providers who care for patients with liver transplantation and chronic liver diseases.
© 2020 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Entities:  

Keywords:  COVID-19; Liver disease; liver transplantation

Mesh：

Year:  2020        PMID： 33107315     DOI： 10.34172/aim.2020.92

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN： 1029-2977            Impact factor:   1.354


  2 in total

Review 1.  Management of COVID-19 patients with chronic liver diseases and liver transplants.

Authors:  Xinyu Hu; Longyan Sun; Zhaoyang Guo; Chao Wu; Xin Yu; Jie Li
Journal:  Ann Hepatol       Date:  2021-12-18       Impact factor: 3.388

2.  Liver dysfunction and SARS-CoV-2 infection.

Authors:  Abraham Edgar Gracia-Ramos; Joel Omar Jaquez-Quintana; Raúl Contreras-Omaña; Moises Auron
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.